Dr. Paula S. Tremayne D.O.

Recommended Articles

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

• Teen Told Her Insulin Pump Would "Crash the Plane"

  ...

• The Promising Future of Gene Therapy and Lymphoma

  Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...

• Understanding a Breast Cancer Biopsy Report

  When a physician suspects that a patient may have breast cancer, they will likely call for a biopsy to be done in order to make an exact diagnosis and begin the prognosis stage. In order to do a biopsy tissue, cells, or lumps must be removed from the breast and sent to the lab in order to be tested....

• Alternative Treatments for Erectile Dysfunction

  What is erectile dysfunction? Erectile dysfunction (ED) is a common disorder affecting men of all ages, although it is more common in men above the age of 50. It affects the ability to have an erection and maintain it for a satisfying sexual experience. To understand the nature of alternative...

• What is Sepsis?

  Sepsis is a serious medical condition characterized by an exaggerated immune response towards an infection. This response causes the release of chemicals, which results in widespread inflammation and blood clotting in different parts of the body. Sepsis may result in sudden drop in the blood...